REFRACTORY MYASTHENIA GRAVIS

Clinical trials for REFRACTORY MYASTHENIA GRAVIS explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY MYASTHENIA GRAVIS trials appear

Sign up with your email to follow new studies for REFRACTORY MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Terminated 1

New treatment tested for severe Muscle-Weakening disease

Disease control Recruiting now

This study is testing an investigational treatment called HN2302 in a small group of adults with myasthenia gravis that hasn't responded well to standard therapies. The main goal is to see if HN2302 is safe and tolerable, while also checking for early signs that it might help imp…

Matched conditions: REFRACTORY MYASTHENIA GRAVIS

Phase: NA • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

REFRACTORY MYASTHENIA GRAVIS

Get alerted when new REFRACTORY MYASTHENIA GRAVIS trials appear

New treatment tested for severe Muscle-Weakening disease